It has been revealed that EphA2 induces YAP/TAZ activation through RHOA activation, and activated YAP/TAZ promotes glutaminolysis through upregulation of GLS1 and SLC1A5 in HER2-positive breast cancer cells (155). The gene discussed is WWTR1; the disease is breast carcinoma.